This is a live streamed only, three day professional conference on advances in cellular therapy. We have gathered together invited speakers from around the world, who you might not otherwise have access to.
Discussing the latest advances in clinical and laboratory-based research for treatment of cancer.
Event Description: While surgery, chemotherapy and radiotherapy have been the mainstays of cancer treatment for many years, progress in our understanding of tumour pathophysiology has contributed to the emergence of a new range of targeted therapeutic options. This event will bring together scientists, clinicians and healthcare professionals to discuss breakthrough research aimed at preventing and curing cancer as well as new techniques and technology to refine conventional approaches, minimise side-effects and relieve the symptoms associated with cancer.
We encourage questions, discussion and debate and have a relaxed atmosphere which generates maximum interaction online.
After registration you will be connected to an online networking site where you will be able to have discussions with all participants of this event, before, during and after the meeting.
Who Should Attend: Research scientists, clinicians and pharmaceutical professionals involved in cancer care and/or the development of novel cancer therapeutics.
Oral Abstract Submission Deadline: 10th August 2017
Early Registration Deadline: 20th September 2017
Poster Submissions Deadline: 24th October 2017
Invited speakers and their talks include
|Antibody-mediated delivery of oncolytic viruses to tumours via monocyte carriage||Dr. Liz Ilett||Leeds Institute of Cancer and Pathology|
Targeting Cancer: New developments in cancer therapeutics has an open abstract session.
Abstracts can be submitted on any subject related to Cancer Therapy.
A Euroscicon live streamed event gives you access to a wider range of international speakers at a fraction of the cost of a real world event. Furthermore, you no longer have to worry about travel or accommodation expenses, or any arrangements you have which clash with our events.
Advisory Board Members
|Anthony J. Berdis||Cleveland State University||United States|
|Ivana Boljevic||Institute for Oncology and Radiology of Serbia||Serbia|
|Nikolaos Georgopoulos||University of Huddersfield||United Kingdom|
|Chames Kermi||Genome Surveillance and Stability Laboratory, Institute of Human Genetics (IGH)||France
|Masoud H Manjili||VCU School of Medicine||United States
|Khalid Shah||Harvard Medical School||United States